Floatz logo

Glucagon

Fatty Liver

Copenhagen University Hospital, Hvidovreprotein_peptideN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

14 Active assets in the Fatty Liver cohort.

Asset / SponsorPhaseRating
Metformin
Leiden University Medical Center
Phase 4BBB
Alpha Tocopherol
Yuen Kah Hay
Phase 4BB
Pioglitazone
Seoul National University Bundang Hospital
Phase 4BB
Raltegravir
Helsinki University Central Hospital
Phase 4BB
Empagliflozin
Seoul National University Bundang Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Glucagon is also rated in:

obesity disorderDormant
BB
Indicative ·
67 / 100
View asset →
type 2 diabetes mellitusDormant
BB
Indicative ·
66 / 100
View asset →
type 1 diabetes mellitusDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →